Valentina Salizzato
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Molecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic Review.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 31, 2025
Identifying high-risk features and improving follow-up strategies in thin melanoma: a retrospective cohort study.
Journal: Clinical and experimental dermatology
Published: December 17, 2024
A model workflow for microfluidic enrichment and genetic analysis of circulating melanoma cells.
Journal: Scientific reports
Published: November 07, 2024
Critical role of protein kinase CK2 in chronic myeloid leukemia cells harboring the T315I BCR::ABL1 mutation.
Journal: International journal of biological macromolecules
Published: July 26, 2024
Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerations.
Journal: The International journal of biological markers
Published: February 26, 2024
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
Journal: Journal of translational medicine
Published: November 30, 2023
Real-world multicentre observational study of effectiveness and toxicity in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 13, 2023
Deciphering the role of protein kinase CK2 in the maturation/stability of F508del-CFTR.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: April 24, 2019
A Journey through the Cytoskeleton with Protein Kinase CK2.
Journal: Current protein & peptide science
Published: October 08, 2018
CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity.
Journal: Scientific reports
Published: May 31, 2017
Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
Journal: Oncotarget
Published: November 03, 2015
Last Updated: 09/26/2026